Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout durationDiana Ferraro, Carlo Pozzilli, Giacomo Lus et al.|Journal of Neurology|2021Cited by 10
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control studyMarta Ponzano, Viola Baione, Irene Schiavetti et al.|Multiple Sclerosis and Related Disorders|2022Cited by 10
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS RegistryPietro Iaffaldano, Augusto Rini, Giuseppe Lucisano et al.|Journal of Neurology|2023Cited by 6
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosisEmilio Portaccio, Maria Pia Amato, M. Betti et al.|Multiple Sclerosis Journal|2025Cited by 4